Literature DB >> 22005059

Assessment of interindividual variability of plasma concentrations after administrazion of high doses of intravenous amoxicillin or cloxacillin in critically ill patients.

M C Verdier1, O Tribut, P Tattevin, C Michelet, D Bentué-Ferrer.   

Abstract

The aim of the present retrospective observational clinical study was to assess the interindividual pharmacokinetic variability of plasma concentrations of amoxicillin or cloxacillin administered in high doses intravenously in critically ill patients, related to renal function or administration method.Four hundred and two plasma concentrations were measured at steady-state with a high performance liquid chromatography technique in 162 patients treated with 100 - 300 mg/kg/day of intravenous amoxicillin or cloxacillin.For both drugs and administration methods, plasma concentrations were significantly higher for patients with creatinine clearance below 60 ml/min, even though doses were adapted for renal impairment. the correlations calculated between plasma concentrations and creatinine level, creatinine clearance or doses were all low. There were fewer outlying drug concentrations in patients receiving continuous rather than intermittent regimens.Our results are in favor of adapting dosages of these beta-lactam antibiotics based on plasma concentrations, especially in cases of renal impairment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005059     DOI: 10.1179/joc.2011.23.5.277

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  6 in total

1.  Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring.

Authors:  Marie-Clémence Verdier; Olivier Tribut; Pierre Tattevin; Yves Le Tulzo; Christian Michelet; Danièle Bentué-Ferrer
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

2.  My paper 10 years later: infective endocarditis in the intensive care unit.

Authors:  Michel Wolff; Bruno Mourvillier; Romain Sonneville; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2014-09-20       Impact factor: 17.440

3.  A Population Pharmacokinetic Analysis of Continuous Infusion of Cloxacillin during Staphylococcus aureus Bone and Joint Infections.

Authors:  Johan Courjon; Margaux Garzaro; Pierre-Marie Roger; Raymond Ruimy; Thibaud Lavrut; Mikaël Chelli; Jean-Luc Raynier; David Chirio; Elisa Demonchy; Laura Cabane; François Jehl; Christophe Trojani; Antoine Grillon; Sylvain Goutelle
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

4.  Protein binding of β-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?

Authors:  Gloria Wong; Scott Briscoe; Syamhanin Adnan; Brett McWhinney; Jacobus Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

5.  Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.

Authors:  Mathilde Neuville; Najoua El-Helali; Eric Magalhaes; Aguila Radjou; Roland Smonig; Jean-François Soubirou; Guillaume Voiriot; Alban Le Monnier; Stéphane Ruckly; Lila Bouadma; Romain Sonneville; Jean-François Timsit; Bruno Mourvillier
Journal:  Ann Intensive Care       Date:  2017-03-22       Impact factor: 6.925

6.  Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps.

Authors:  Guillaume Binson; Claire Grignon; Gwenaël Le Moal; Pauline Lazaro; Jérémy Lelong; France Roblot; Nicolas Venisse; Antoine Dupuis
Journal:  PLoS One       Date:  2019-08-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.